1. Screening and Management of TB among HIV cases 1.1 Ward Physicians Inform the HIV center regarding referrals of PLHIV with TB to TB Center 1.2 HIV.

Slides:



Advertisements
Similar presentations
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Advertisements

Common/shared responsibilities between jobs.
HIV Counselling and Testing
The Roadmap to Successful Xpert Implementation - 37 steps -
HIV Exposure: What Emergency Response Agencies Need to Know About Accessing Information.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Project Title. Project Title: to improve the care of people who are infected with both TB and HIV, through training and collaborative care initiatives.
ClASS MODULES: BREAKOUT SESSIONS. ClASS CLINICAL MODULE.
GUIDELINES & TOOLS for HOSPITAL DOTS LINKAGE (HDL)
Country Progress Report Philippines
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
Tuberculosis Follow up Care PA Department of Health Role Maxine Kopiec Community Health Nursing Supervisor April 24, 2015.
Module 1: Course Overview. Course Objectives Teach you everything you need to know about the TB Program Describe TB the roles and responsibilities of.
Chronic HIV Care with ART. CHALLENGES TO SELF-MANAGEMENT AND QUALITY CHRONIC CARE The acute care paradigm -Reactive care -Patient who is in office now.
National TB/ Leprosy Programme Manager
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
PROVIDER INITIATED COUNSELING AND TESTING THATO FARIRAI BIRCHWOOD HOTEL AUGUST 10,2010 National Guidelines for HIV Counseling and Testing in Clinical Settings:
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
TB/HIV/AIDS Prevention and Management in the Workplace: Forging new partnerships- by Thinking Ahead Anthony Pramualratana.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Managing Pre-Hospital Exposures PRODUCED BY RI Department of Health, Division of EMS & Hospital Association of Rhode Island.
Module 14: Isoniazid Preventive Therapy Programme.
Downloaded from Accelerate scaling up of TB/HIV activities in Tanzania Dr. N.G.SIMKOKO WHO/NTLP - Tanzania.
TB/HIV Workshop: DRC Group Work and Country Presentations.
Unit 10. Monitoring and evaluation
Patient Safety Friendly Hospital Intiative Purpose Implementation of a set of patient safety standards in hospitals Implementation of a set of patient.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Implementation of Collaborative TB/HIV Activities by ICAP: Success and Challenges Andrea Howard, M.D., M.S. 14 th Core Group Meeting of TB/HIV Working.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Haileyesus Getahun Stop TB Department WHO Re-conceptualizing ICF and IPT: global progress to date 14 th Core Group Meeting of the TB/HIV Working Group,
Integrating TB in the Workplace Presentation by: Miss. D.M.Nokwe 15 th of October 2009 TB Directorate.
Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.
PERSPECTIVES FROM THE FIELD DR LYDIA MUNGHERERA TASO (The Aids Support Organisation) UGANDA REVERSING THE TIDE OF TB.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
TB infection control and prevention of XDR Group II.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
1 Module 2: HIV Counseling and Testing for PMTCT Ministry of Health/HAPCO, Ethiopia.
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
Objectives Upon completion of this training, agencies will be able to:
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
TB- HIV Collaborative activities in Romania- may 2006 status
Patient Medical Records
This is an archived document.
TB/HIV surveillance : Who is going to get the job done?
Find and Treat All Missing Persons with TB
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Tuberculosis and the President’s Emergency Plan for AIDS Relief
Pharmacy practice and the healthcare system Ola Ali Nassr
5th edition NTP MANUAL OF PROCEDURES Introduction and Highlights
Contents Objectives Definition of Terms Policies Procedures
DR-TB Case-finding and Referral Procedures
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
11 iii. Define management and supervision roles and responsibilities
South Africa: From ProTest to Nationwide Implementation
From ProTEST to Nationwide Implementation
The STOP TB Strategy – 2009 VISION: A TB-free world
Routine Counselling and HIV testing (CT) for TB patients in Malawi: Rhehab Chimzizi TB-HIV Programme officer National TB Control Programme-Malawi.
5th edition NTP MANUAL OF PROCEDURES TB-DOTS Referral System
Pharmacy Sector SECTOR COMMITMENT TO END TB
5th edition NTP MANUAL OF PROCEDURES Reporting
5th edition NTP MANUAL OF PROCEDURES Case Finding
Presentation transcript:

1. Screening and Management of TB among HIV cases 1.1 Ward Physicians Inform the HIV center regarding referrals of PLHIV with TB to TB Center 1.2 HIV Center HCWs Obtain and record the following:: a. Previous history of TB or treatment of TB and other lung ailments b. Previous intake of INH c. Previous current medications taken such as Cotrimoxazole Preventive Therapy (CPT) including ARV

1.2.2 Perform baseline examination to all PLHIV such as DSSM, CXR, CBC, SGPT, SGOT, Triglycerides, Total Cholesterol, LDL, HDL Urinalysis and CD4 count Follow the Diagnostic Algorithm of Gene Xpert for TB in PLHIV (See Annex 1) Refer all PLHIV to TB Center for diagnosis and management Supervise the drug intake of PLHIV with TB disease and TB infection. * Only at trained health care provider and / or significant others shall provide DOT Obtain consent from the PLHIV for adherence counseling and contact investigation.

1.2.7 Record and Report all cases ensuring strict confidentiality using code identifiers. a. Use existing forms by the NTP and NASCPCP such as the TB Registry and the AIDS Registry, including “TB/ HIV Masterlist” and “TB/HIV IPT Registry” developed by the TB and HIV Working Group in San Lazaro Hospital. b. Record all medical information of PLHIV and submit monthly report to the Hospital Epidemiology Center Chief, NTP-DOH and Manila Health Department and quarterly report to Center for Health Development- Metro Manila (CHD-MM).

c. Collect data for TB and HIV Collaboration in SLH reflecting the case finding and case holding indicators of the NTP and records of the AIDS Registry. d. Report the case finding, case holding and treatment outcomes to Hospital Epidemiology Unit and NASPCP on a quarterly basis. 1.3 TB Center Acknowledge referrals of all PLHIV from HIV Center and other wards.

1.3.2 Obtain and record the following: a. Previous history of TB or treatment of TB and other lung ailments. b. Previous intake of INH c. Previous current medications such as Cotrimoxazole Preventive Therapy Follow the Diagnostic Algorithm of Gene Xpert for TB in PLHIV (See Annex 1) Motivate all PLHIV to undergo Gene Xpert at the SLH main laboratory Refer all PLHIV to SLH PMDT (Programmatic Management for Drug Resistant TB) Treatment Center for MDR-TB Screening and Evaluation.

1.3.6 Ensure that all PLHIV referred to SLH-PMDT Treatment Center were able to access services of the treatment center Provide feedback to appropriate facilities or centers regarding the result of examinations and evaluations among PLHIV to facilitate prompt intervention and management Recording and Reporting a. Ensure strict confidentiality of records and reports at all times. b. Utilize existing records and reports by the NTP and NASPCP such as the TB register and the AIDS Registry including the “TB/HIV Masterlist” and the TB / HIV IPT Register” developed by the TB and HIV Working Group in San Lazaro Hospital.

c. Record all medical information of PLHIV and monthly report to the Hospital Epidemiology Center Chief, NTP- DOH Health Department and quarterly report to CHD- MM. d. Collect data for TB and HIV Collaboration in SLH reflecting the case finding and case holding indicators of the NTP and records of the AIDS Registry. e. Report the case finding, case holding and treatment outcomes to Hospital Epidemiology Unit and NASPCP on quarterly basis.

2. Screening and Management of HIV among confirmed TB cases. 2.1 TB/ HIV Point Person a. Provide group education to all patients diagnosed with TB and MDR-TB in the TB Center. b. Offer HIV counseling and testing (HCT) to all confirmed TB cases. c. Secure informed consent prior to HIV screening. d. Refer for HIV screening at SLH-Main Laboratory. e. Provide post test counseling to all screened HIV cases and refer confirmed cases to HIV treatment hub. f. Re-offer HIV counseling and testing (HCT), on succeeding follow up, to those who would have refused the initial testing.

2.2 HIV Point Person a. Manage HIV cases based on National guidelines for the clinical management of HIV infections and AIDS. b. Offer HCT to partners of confirmed HIV cases with mutual disclosure c. Refer PLHIV with TB for treatment at the TB Center.

3. Implementing Mechanism of TB/ HIV Collaboration A. Duties and Responsibilities 1. San Lazaro Hospital Management Team / TB HIV Technical Working Group - (composed of the following: Medical Center Chief, Chief of Clinics, Chief Clinical Division, Department Heads of TB and HIV Centers, NTP physicians, Laboratory and Public Health Service) a. Oversee the implementation on collaborative approach and cross referral mechanism for the TB/HIV programs.

b. Facilitates trainings, programs and activities on TB/HIV prevention and control. c. Monitors implementation and evaluates outcome of TB/HIV Programs on quarterly basis. d. Formulate policies / guidelines in the implementation of TB/HIV collaboration based on NASPCP and NTP guidelines.  Strengthen cross referral mechanisms between TB and HIV centers to provide TB/HIV services.  Update management of TB/HIV co-infection to ensure quality of care among cases with TB/HIV co-infection.

e. Provide forum for the discussion of issues/concerns. f. Set the directions for TB/HIV call vis-à-vis NTP /NASPCP guidelines. g. Collaborates with different agencies (DOH, WHO, UNAIDS, UNICEF, NGO’s) for any related activities

2. TB/HIV Core Group a. Conduct capability building activities on TB/HIV collaborative and related activities to all HCWs involved in TB/HIV program. b. Ensure that there is enough manpower in the TB/HIV Centers to implement the program. c. Submit reports required by CHD-MM on quarterly basis. d. Evaluated and monitor implementation of the plan.

B. HCWs Specific Task 1. The HIV Center Personnel shall ensure a. Adherence to the TB / HIV protocol and Infection Control Guidelines. b. Involvement of PLHIV and their significant others in the treatment, care and support. c. Strengthening of support groups in collaboration with PLHIV and their families, for the education, prevention, treatment and care.

d. Accurate recording and reporting of accomplishments on a regular basis. e. Co-management of all PLHIV referrals from other wards and departments.

2. The TB Center/ Personnel shall ensure: a. Adherence to the TB / HIV protocol and Infection Control Guidelines. b. Co – management of all referrals from the HIV Department to the DOTS Facility c. Initiation and provision of quality DOTS services to all PLHIV with active TB in accordance with the NTP Protocol. Political commitment with increased and sustained financing case detection through quality assured bacteriology

Standardized treatment with supervision and patient support Effective drug supply and management system Monitoring and evaluation system and impact measurement d. Contact tracing of the families of the index cases.

3. Laboratory Role a. Evaluates request forms and encodes patient data in the Laboratory Information System ( LIS ) b. Collects specimen from the patient and processes them in the Serology section. Only reactive specimens are subjected for confirmatory testing at SLH-National Reference Laboratory. c. Validates the test results thru encoding using LIS. d. Releases the result to the walk-in patients or forwards the results to the requesting physician for in- patients

4. Infection Control Committee Role a. Oversee the implementation of hospital’s infection control specifically on high risk areas for TB and HIV patients are commonly admitted (1. ER 2. Adult ward, 3. H4 center 4. TB Center and Phil health ward) b. Monitor and supervise infection control policies and procedures being complied with on the above identified areas. c. Update hospital’s policies and guidelines on TB and HIV prevention and control.

4. Infection Control Committee Role d. Conduct training activities on PCI related with TB and HIV for all hospital personnel. e. Conduct regular surveillance on the presence of Healthcare Associated Infection among admitted patients with TB and Give regular feedback on anti microbial resistance areas mentioned on 4.1 f. Conduct surveillance on occupation risk exposure.

4. Infection Control Committee Role g. Conduct hospital outbreak investigation. h. Provide expert opinions on prevention and control of infection within the hospital and other PCI related matters. i. Submit annual and during outbreaks accomplishment report/feedback/recommendations to the Medical Center Chief II and copy furnish Chief Medical Professional

5. The PLHIV, significant others and their families involved in treatment, care and support program shall: a.Provide accurate information on the clinical history for proper case management and treatment. b.Proactively seek information and participate in learning sessions on TB and HIV for informed decisions in the prevention, treatment, care and support. c.Cooperate and adhere to the TB and HIV protocol.

5. The PLHIV, significant others and their families involved in treatment, care and support program shall: c. Provide treatment partners to be trained by SLH HCWs following established protocols and procedures d. Participate in support groups for TB and HIV that will provide essential information and feedback to enhance the quality of services of the TB and HIV program. 3. Implementing Mechanism of TB/ HIV Collaboration